Document Type : Original Article


1 Department of Pathobiology, Faculty of Veterinary Medicine, Urmia University, Urmia, Iran

2 Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

3 Department of Applied Cell Sciences, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran

4 Solid Tumor Research Center, Cellular and Molecular Medicine Institute, Urmia University of Medical Sciences, Urmia, Iran


Diabetes mellitus is one of the leading causes of death globally. The development of cellular injuries and impaired energy metabolism are involved in the pathogenesis of diabetes mellitus, leading to severe diabetic complications in different tissues such as the pulmonary tissue. Autophagy is a double-edged sword mechanism required for maintaining cell survival and homeostasis. Any abnormalities in autophagic response can lead to the progression of several diseases. Here, we aimed to assess the effect of diabetic conditions on the autophagic response and exosome secretion in a rat model of type 2 diabetes mellitus. The experimental diabetic group received 45.00 mg kg-1 streptozocin (STZ) dissolved in 0.10 M sodium citrate. After 4 weeks, we monitored autophagic response and exosome biogenesis in the pulmonary tract using immunohistochemistry (IHC) and Real-time polymerase chain reaction analyses, respectively. Histological examination revealed the interstitial bronchopneumonia indicating enhanced immune cell infiltration into the pulmonary parenchyma. Immunohistochemistry staining displayed an enhanced autophagic response through the induction of microtuble-associated protein light chain 3 (LC3) and protein sequestosome 1 (P62) compared to the control rats. These changes coincided with significant induction of tetraspanin CD63 in STZ-induced diabetic rats relative to control rats. In conclusion, a diabetic condition can increase the autophagic response in pulmonary tissue. The accumulation of P62 in the pulmonary niche exhibits an incomplete autophagic response. The abnormal autophagy response can increase pulmonary cell sensitivity against injuries.


  1. No authors Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997; 20(7): 1183-1197.
  2. Bogun M, Inzucchi SE. Inpatient management of diabetes and hyperglycemia. Clin Ther; 2013; 35(5): 724733.
  3. Attele AS, Zhou YP, Xie JT, et al. Antidiabetic effects of Panax ginseng berry extract and the identification of an effective component. Diabetes 2002; 51(6): 1851-1858.
  4. Bang H, Kwak JH, Ahn HY, et al. Korean red ginseng improves glucose control in subjects with impaired fasting glucose, impaired glucose tolerance, or newly diagnosed type 2 diabetes mellitus. J Med Food 2014; 17(1): 128-134.
  5. Pourheydar M, Hasanzadeh S, Razi M, et al. Effects of liraglutide on sperm characteristics and fertilization potential following experimentally induced diabetes in mice. Vet Res Forum; 2021; 12(1): 109-116.
  6. Ito T, Uchikoshi F, Tori M, et al. Immunological characteristics of pancreas transplantation: review and our experimental experience. Pancreas 2003; 27(1): 31-37.
  7. Domínguez-Bendala J, Inverardi L, Ricordi C. Regeneration of pancreatic beta-cell mass for the treatment of diabetes. Expert Opin Biol Ther 2012; 12(6): 731-741.
  8. Gläser S, Krüger S, Merkel M, et al. Chronic obstructive pulmonary disease and diabetes mellitus: a systematic review of the literature. Respiration 2015; 89(3): 253-264.
  9. Rezabakhsh A, Ahmadi M, Khaksar M, et al. Rapamycin inhibits oxidative/nitrosative stress and enhances angiogenesis in high glucose-treated human umbilical vein endothelial cells: Role of autophagy. Biomed Pharmacother 2017; 93: 885-894.
  10. Hassanpour M, Rezabakhsh A, Pezeshkian M, et al. Distinct role of autophagy on angiogenesis: highlights on the effect of autophagy in endothelial lineage and progenitor cells. Stem Cell Res Ther 2018; 9: 305. doi: 10.1186/s13287-018-1060-5.
  11. Bloemberg D, Quadrilatero J. Autophagy, apoptosis, and mitochondria: molecular integration and physiological relevance in skeletal muscle. Am J Physiol Cell Physiol 2019; 317(1): C111-C130.
  12. Xu J, Camfield R, Gorski SM. The interplay between exosomes and autophagy–partners in crime. J Cell Sci 2018; 131(15): jcs215210. doi: 10.1242/jcs.215210.
  13. Dai J, Su Y, Zhong S, et al. Exosomes: key players in cancer and potential therapeutic strategy. Signal Transduct Target Ther 2020; 5(1): 145. doi: 10.1038/s41392-020-00261-0
  14. Ha D, Yang N, Nadithe V. Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges. Acta Pharm Sin B 2016; 6(4): 287-296.
  15. Garcia-Contreras M, Brooks RW, Boccuzzi L, et al. Exosomes as biomarkers and therapeutic tools for type 1 diabetes mellitus. Eur Rev Med Pharmacol Sci 2017; 21(12): 2940-2956.
  16. Schröder J, Lüllmann-Rauch R, Himmerkus N, et al. Deficiency of the tetraspanin CD63 associated with kidney pathology but normal lysosomal function. Mol Cell Biol 2009; 29(4): 1083-1094.
  17. Almohammai A, Rahbarghazi R, Keyhanmanesh R, et al. Asthmatic condition induced the activity of exosome secretory pathway in rat pulmonary tissues. J Inflamm (Lond) 2021; 18(1): 14. doi: 10.1186/s12950-021-00275-7.
  18. Deng ZB, Poliakov A, Hardy RW, et al. Adipose tissue exosome-like vesicles mediate activation of macrophage-induced insulin resistance. Diabetes 2009; 58(11): 2498-2505.
  19. Wu Y, Jin Y, Sun T, et al. p62/SQSTM1 accumulation due to degradation inhibition and transcriptional activation plays a critical role in silica nanoparticle-induced airway inflammation via NF-κB activation. J Nanobiotechnology 2020; 18(1): 77. doi: 10.1186/ s12951-020-00634-1.
  20. Feng X, Chen L, Guo W, et al. Graphene oxide induces p62/SQSTM-dependent apoptosis through the impair-ment of autophagic flux and lysosomal dysfunction in PC12 cells. Acta biomater 2018; 81: 278-292.
  21. Gonzalez CD, Carro Negueruela MP, Nicora Santamarina C, et al. Autophagy dysregulation in diabetic kidney disease: from pathophysiology to pharmacological interventions. Cells 2021; 10(9): 2497. doi: 10.3390/cells10092497.
  22. Stienstra R, Haim Y, Riahi Y, et al. Autophagy in adipose tissue and the beta cell: implications for obesity and diabetes. Diabetologia 2014; 57(8): 1505-1516.
  23. Bhattacharya D, Mukhopadhyay M, Bhattacharyya M, et al. Is autophagy associated with diabetes mellitus and its complications? A review. Excli J 2018; 17: 709-720.
  24. Barlow AD, Thomas DC. Autophagy in diabetes: β-cell dysfunction, insulin resistance, and complications. DNA Cell Biol 2015; 34(4): 252-260.
  25. Igawa H, Kikuchi A, Misu H, et al. p62-mediated autophagy affects nutrition-dependent insulin receptor substrate 1 dynamics in 3T3-L1 preadipocytes. J Diabetes Investig 2019; 10(1): 32-42.
  26. Castaño C, Novials A, Párrizas M. Exosomes and diabetes. Diabetes Metab Res Rev 2019; 35(3): e3107. doi: 10.1002/dmrr.3107.